Pharmaceutical Executive July 29, 2024
Mike Hollan

MGI Tech Co. issued a statement detailing the use of its technology in improving the rates of genomic sequencing in South Africa.

Genomic technology is being used in South Africa to research and identify natural controls for HIV infections. MGI Tech Co., announced its sequencing tools are being utilized at the South African Medical Research Council (SAMRC) and the University of KwaZulu-Natal. HIV continues to be a significant problem in the region, which has the largest number of people living with HIV.

However, MGI states that the African human genome is the least sequenced among human genomes. This presents a significant problem, as proper genetic sequencing allows experts to create more targeted treatment programs and create more effective treatments for...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider
Bringing genomics closer to patients: 3 takeaways from Henry Ford Health
Oncologist talks personalized medicine for pancreatic cancer
AI offers a step above genomic solutions
How Mayo Clinic is using real-world data to advance precision medicine
Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI

Share This Article